Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection

OBJECTIVES: Treatment with pegylated interferon and ribavirin may prevent progression of liver disease among patients with chronic hepatitis C virus infection (HCV). Treatment initiation is based on published clinical eligibility criteria, patients’ willingness to undergo treatment and likelihood of...

Descripción completa

Detalles Bibliográficos
Autores principales: Livingston, Stephen E., Townshend-Bulson, Lisa J., Bruden, Dana L., McMahon, Brian J., Homan, Chriss E., Gove, James E., Deubner, Heike, Bruce, Michael G., Robinson, Renee F., Gretch, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417585/
https://www.ncbi.nlm.nih.gov/pubmed/22564468
http://dx.doi.org/10.3402/ijch.v71i0.18445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417585/
https://www.ncbi.nlm.nih.gov/pubmed/22564468
http://dx.doi.org/10.3402/ijch.v71i0.18445

Ejemplares similares